Disease burden of congenital cytomegalovirus infection at school entry age: Study design, participation rate and birth prevalence

Epidemiology and Infection

Volumn 144, Issue 7, 2016, Pages 1520-1527

  Korndewal, M J ^a,b   Vossen, A C T M ^b   Cremer, J ^a   Van Binnendijk, R S ^a   Kroes, A C M ^b   Van Der Sande, M A B ^a,c   Oudesluys Murphy, A M ^b   De Melker, H E ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Cytomegalovirus; epidemiology; paediatrics

Indexed keywords

ARTICLE; CHILD; CHILD DEVELOPMENT; COHORT ANALYSIS; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRIED BLOOD SPOT TESTING; HEALTH STATUS; HUMAN; INFORMED CONSENT; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PATIENT PARTICIPATION; POLYMERASE CHAIN REACTION; PREVALENCE; RETROSPECTIVE STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; INFANT; MALE; METHODOLOGY; NETHERLANDS; NEWBORN; NEWBORN SCREENING; PHYSIOLOGY; PRESCHOOL CHILD; VIROLOGY;

CHILD; CHILD, PRESCHOOL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DRIED BLOOD SPOT TESTING; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEONATAL SCREENING; NETHERLANDS; POLYMERASE CHAIN REACTION; PREVALENCE; RESEARCH DESIGN; RETROSPECTIVE STUDIES;

EID: 84946780418     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268815002708     Document Type: Article

References (37)

1. Griffiths P, Baraniak I, Reeves M. The pathogenesis of human cytomegalovirus. Journal of Pathology 2015; 235: 288-297.
2. Boppana SB, et al. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. New England Journal of Medicine 2001; 344: 1366-1371.
3. Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Reviews in Medical Virology 2007; 17: 253-276.
4. Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Reviews in Medical Virology 2007; 17: 355-363.
5. Townsend CL, Peckham CS, Tookey PA. Surveillance of congenital cytomegalovirus in the UK and Ireland. Archives of Disease in Childhood (Fetal and Neonatal Edition) 2011; 96: F398-403.
6. CBS Statistics Netherlands. Statline population and population dynamics; month, quarter and year (http://statline.cbs.nl/Statweb/publication/?DM=SLEN&PA=37943eng&D1=0,10-22&D2=221-237&LA=EN&VW=T). Accessed 24 April 2015.
7. Boeckh M, et al. Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR. Journal of Clinical Microbiology 2004; 42: 1142-1148.
8. Kalpoe JS, et al. Validation of clinical application of cytomegalovirus plasma DNA load measurement and definition of treatment criteria by analysis of correlation to antigen detection. Journal of Clinical Microbiology 2004; 42: 1498-1504.
9. Doig KB, et al. The Child Development Inventory: A developmental outcome measure for follow-up of the highrisk infant. Journal of Pediatrics 1999; 135: 358-362.
10. Ireton H, Glascoe FP. Assessing children's development using parents' reports. The Child Development Inventory. Clinical Pediatrics 1995; 34: 248-255.
11. Korver AM, et al. DECIBEL study: Congenital cytomegalovirus infection in young children with permanent bilateral hearing impairment in The Netherlands. Journal of Clinical Virology 2009; 46 (Suppl. 4): S27-31.
12. Varni JW, Limbers CA. The pediatric quality of life inventory: measuring pediatric health-related quality of life from the perspective of children and their parents. Pediatric Clinics of North America 2009; 56: 843-863.
13. Varni JW, Seid M, Kurtin PS. PedsQL 4 0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Medical Care 2001; 39: 800-812.
14. Varni JW, Seid M, Rode CA. The PedsQL: measurement model for the pediatric quality of life inventory. Medical Care 1999; 37: 126-139.
15. Varni JW, et al. The PedsQL 4 0 Generic Core Scales: sensitivity, responsiveness, and impact on clinical decision-making. Journal of Behavioral Medicine 2002; 25: 175-193.
16. Chan KS, et al. The PedsQL: reliability and validity of the short-form generic core scales and asthma module. Medical Care 2005; 43: 256-265.
17. Gandek B, et al. Tests of data quality, scaling assumptions, and reliability of the SF-36 in eleven countries: results from the IQOLA Project. International Quality of Life Assessment. Journal of Clinical Epidemiology 1998; 51: 1149-1158.
18. Gandek B, et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. Journal of Clinical Epidemiology 1998; 51: 1171-1178.
19. Neto EC, et al. Newborn screening for congenital infectious diseases. Emerging Infectious Diseases 2004; 10: 1068-1073.
20. Lebech M, Petersen E. Neonatal screening for congenital toxoplasmosis in Denmark: presentation of the design of a prospective study. Scandinavian Journal of Infectious Diseases Supplementum 1992; 84: 75-79.
21. Sander J, Niehaus C. Screening for rubella IgG and IgM using an ELISA test applied to dried blood on filter paper. Journal of Pediatrics 1985; 106: 457-461.
22. Fowler KB, et al. Newborn hearing screening: will children with hearing loss caused by congenital cytomegalovirus infection be missed? Journal of Pediatrics 1999; 135: 60-64.
23. Foulon I, et al. A 10-year prospective study of sensorineural hearing loss inchildrenwithcongenital cytomegalovirus infection. Journal of Pediatrics 2008; 153: 84-88.
24. de Vries JJ, et al. Congenital cytomegalovirus infection in The Netherlands: birth prevalence and risk factors. Journal of Medical Virology 2011; 83: 1777-1782.
25. Ahlfors K, Ivarsson SA, Harris S. Report on a long-term study of maternal and congenital cytomegalovirus infection in Sweden. Review of prospective studies available in the literature. Scandinavian Journal of Infectious Diseases 1999; 31: 443-457.
26. de Vries JJ, et al. The apparent paradox of maternal seropositivity as a risk factor for congenital cytomegalovirus infection: A population-based prediction model. Reviews in Medical Virology 2013; 23: 241-249.
27. Korndewal MJ, et al. Cytomegalovirus infection in The Netherlands: seroprevalence, risk factors, and implications. Journal of Clinical Virology 2015; 63: 53-58.
28. Korver AM, et al. Awareness of congenital cytomegalovirus among doctors in The Netherlands. Journal of Clinical Virology 2009; 46 (Suppl. 4): S11-15.
29. Pereboom MT, et al. Maternal cytomegalovirus infection prevention: The role of Dutch primary care midwives. Midwifery 2014; 30: 1196-1201.
30. de Vries JJ, et al. Evaluation of DNA extraction methods for dried blood spots in the diagnosis of congenital cytomegalovirus infection. Journal of Clinical Virology 2009; 46 (Suppl. 4): S37-42.
31. Boppana SB, et al. Dried blood spot real-time polymerase chain reaction assays to screen newborns for congenital cytomegalovirus infection. Journal of the American Medical Association 2010; 303: 1375-1382.
32. Barbi M, Binda S, Caroppo S. Diagnosis of congenital CMV infection via dried blood spots. Reviews in Medical Virology 2006; 16: 385-392.
33. Wang L, et al. Dried blood spots PCR assays to screen congenital cytomegalovirus infection: A meta-analysis. Virology Journal 2015; 12: 60.
34. Lanari M, et al. Neonatal cytomegalovirus blood load and risk of sequelae in symptomatic and asymptomatic congenitally infected newborns. Pediatrics 2006; 117: e76-83.
35. Boppana SB, et al. Congenital cytomegalovirus infection: association between virus burden in infancy and hearing loss. Journal of Pediatrics 2005; 146: 817-823.
36. Rivera LB, et al. Predictors of hearing loss in children with symptomatic congenital cytomegalovirus infection. Pediatrics 2002; 110: 762-767.
37. Cannon MJ, et al. Universal newborn screening for congenital CMV infection: what is the evidence of potential benefit? Reviews in Medical Virology 2014; 24: 291-307.